These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 27055517)

  • 1. Pompe Disease: Diagnosis and Management. Evidence-Based Guidelines from a Canadian Expert Panel.
    Tarnopolsky M; Katzberg H; Petrof BJ; Sirrs S; Sarnat HB; Myers K; Dupré N; Dodig D; Genge A; Venance SL; Korngut L; Raiman J; Khan A
    Can J Neurol Sci; 2016 Jul; 43(4):472-85. PubMed ID: 27055517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis and treatment of late-onset Pompe disease in the Middle East and North Africa region: consensus recommendations from an expert group.
    ; Al Jasmi F; Al Jumah M; Alqarni F; Al-Sanna'a N; Al-Sharif F; Bohlega S; Cupler EJ; Fathalla W; Hamdan MA; Makhseed N; Nafissi S; Nilipour Y; Selim L; Shembesh N; Sunbul R; Tonekaboni SH
    BMC Neurol; 2015 Oct; 15():205. PubMed ID: 26471939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [POMPE DISEASE - GUIDELINES FOR DIAGNOSIS AND MANAGEMENT OF ADULT PATIENTS].
    Pećin I; Muačević-Katanec D; Šimić I; Fumić K; Potočki K; Šućur N; Reiner Ž;
    Lijec Vjesn; 2015; 137(7-8):216-8. PubMed ID: 26502670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Consensus treatment recommendations for late-onset Pompe disease.
    Cupler EJ; Berger KI; Leshner RT; Wolfe GI; Han JJ; Barohn RJ; Kissel JT;
    Muscle Nerve; 2012 Mar; 45(3):319-33. PubMed ID: 22173792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pompe disease: a review of the current diagnosis and treatment recommendations in the era of enzyme replacement therapy.
    Katzin LW; Amato AA
    J Clin Neuromuscul Dis; 2008 Jun; 9(4):421-31. PubMed ID: 18525427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diagnosis and treatment of Pompe disease].
    Bravo-Oro A; de la Fuente-Cortez B; Molina-García A; Romero-Díaz V; Rodríguez-Leyva I; Esmer-Sánchez Mdel C;
    Rev Med Inst Mex Seguro Soc; 2013; 51(5):536-51. PubMed ID: 24144148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical sequelae of 17 cases with glycogen storage disease type II/Pompe disease].
    Zhang HB; Zhang WM; Qiu JJ; Meng Y; Qiu ZQ
    Zhonghua Er Ke Za Zhi; 2012 Jun; 50(6):415-9. PubMed ID: 22931935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical guidelines for late-onset Pompe disease.
    Barba-Romero MA; Barrot E; Bautista-Lorite J; Gutierrez-Rivas E; Illa I; Jimenez LM; Ley-Martos M; Lopez de Munain A; Pardo J; Pascual-Pascual SI; Perez-Lopez J; Solera J; Vilchez-Padilla JJ
    Rev Neurol; 2012 Apr; 54(8):497-507. PubMed ID: 22492103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methods of diagnosis of patients with Pompe disease: Data from the Pompe Registry.
    Kishnani PS; Amartino HM; Lindberg C; Miller TM; Wilson A; Keutzer J
    Mol Genet Metab; 2014; 113(1-2):84-91. PubMed ID: 25085280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Practical Recommendations for Diagnosis and Management of Respiratory Muscle Weakness in Late-Onset Pompe Disease.
    Boentert M; Prigent H; Várdi K; Jones HN; Mellies U; Simonds AK; Wenninger S; Barrot Cortés E; Confalonieri M
    Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27763517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic criteria for late-onset (childhood and adult) Pompe disease.
    American Association of Neuromuscular & Electrodiagnostic Medicine
    Muscle Nerve; 2009 Jul; 40(1):149-60. PubMed ID: 19533647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diagnosis recommendations for late-onset Pompe disease].
    Brito-Avô L; Alves JD; Costa JM; Valverde A; Santos L; Araújo F; Aguiar P; Marinho A; Oliveira A; Gomes D
    Acta Med Port; 2014; 27(4):525-9. PubMed ID: 25203965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Replacing acid alpha-glucosidase in Pompe disease: recombinant and transgenic enzymes are equipotent, but neither completely clears glycogen from type II muscle fibers.
    Raben N; Fukuda T; Gilbert AL; de Jong D; Thurberg BL; Mattaliano RJ; Meikle P; Hopwood JJ; Nagashima K; Nagaraju K; Plotz PH
    Mol Ther; 2005 Jan; 11(1):48-56. PubMed ID: 15585405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complete correction of acid alpha-glucosidase deficiency in Pompe disease fibroblasts in vitro, and lysosomally targeted expression in neonatal rat cardiac and skeletal muscle.
    Pauly DF; Johns DC; Matelis LA; Lawrence JH; Byrne BJ; Kessler PD
    Gene Ther; 1998 Apr; 5(4):473-80. PubMed ID: 9614571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is it Pompe Disease? Australian diagnostic considerations.
    Tchan M; Henderson R; Kornberg A; Kairaitis K; Fuller M; Davis M; Ellaway C; Reardon K; Corbett A; Needham M; McKelvie P
    Neuromuscul Disord; 2020 May; 30(5):389-399. PubMed ID: 32418839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Juvenile Pompe disease: retrospective clinical study].
    Loureiro Neves F; Garcia PC; Madureira N; Araújo H; Rodrigues F; Estêvão MH; Lacerda L; Diogo Matos LM
    Acta Med Port; 2013; 26(4):361-70. PubMed ID: 24016645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Newborn screening for Pompe disease: synthesis of the evidence and development of screening recommendations.
    Kemper AR; Hwu WL; Lloyd-Puryear M; Kishnani PS
    Pediatrics; 2007 Nov; 120(5):e1327-34. PubMed ID: 17974725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The French Pompe registry. Baseline characteristics of a cohort of 126 patients with adult Pompe disease.
    Laforêt P; Laloui K; Granger B; Hamroun D; Taouagh N; Hogrel JY; Orlikowski D; Bouhour F; Lacour A; Salort-Campana E; Penisson-Besnier I; Sacconi S; Zagnoli F; Chapon F; Eymard B; Desnuelle C; Pouget J;
    Rev Neurol (Paris); 2013; 169(8-9):595-602. PubMed ID: 24008051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Argentine consensus on late-onset Pompe's disease].
    Dubrovsky A; Fulgenzi E; De Vito EL; Barroso F; Berardo A; Bettini M; Binaghi D; Calabrese E; Carlés D; Chaves M; Chloca F; Conti E; Corderi J; Di Gennaro F; Ferradás N; Jáuregui A; Lubieniecki F; Mazia C; Medina M; Pirra L; Politei J; Reisin R; Rosa AL; Rugiero M; Salutto V; Schenone A; Sussini M; Taratuto AL
    Medicina (B Aires); 2018; 78 Suppl 1():1-23. PubMed ID: 30179846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nosology of lysosomal glycogen storage diseases without in vitro acid maltase deficiency. Delineation of a neonatal form.
    Verloes A; Massin M; Lombet J; Grattagliano B; Soyeur D; Rigo J; Koulischer L; Van Hoof F
    Am J Med Genet; 1997 Oct; 72(2):135-42. PubMed ID: 9382133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.